PNC Financial Services Group
CDIO icon

PNC Financial Services Group’s Cardio Diagnostics CDIO Stock Holding History

PNC Financial Services Group’s Portfolio CDIO Stock Details CDIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,350
Closed -$3.66K – 5189
2025
Q4 		$3.66K Hold
1,350
– – ﹤0.01% 4349
2025
Q3 		$5.41K Hold
1,350
– – ﹤0.01% 4167
2025
Q2 		$4.86K Hold
1,350
– – ﹤0.01% 4149
2025
Q1 		$13.4K Hold
1,350
– – ﹤0.01% 3717
2024
Q4 		$37.1K Hold
1,350
– – ﹤0.01% 3258
2024
Q3 		$9.03K Hold
1,350
– – ﹤0.01% 3837
2024
Q2 		$22.3K Hold
1,350
– – ﹤0.01% 3430
2024
Q1 		$57.5K Hold
1,350
– – ﹤0.01% 2929
2023
Q4 		$101K Hold
1,350
– – ﹤0.01% 2603
2023
Q3 		$13.8K Hold
1,350
– – ﹤0.01% 3622
2023
Q2 		$48.2K Hold
1,350
– – ﹤0.01% 3082
2023
Q1 		$158K Buy
+1,350
New +$106K ﹤0.01% 2293

Other funds holding CDIO

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

PNC Financial Services Group's CDIO Position: Q1 2026 in Review

PNC Financial Services Group sold out of Cardio Diagnostics (CDIO) in Q1 2026, closing a stake of 1,350 shares — an estimated $3.66K sold.

PNC Financial Services Group first reported a position in CDIO in Q1 2023 and held it in 12 quarters. The position peaked at $158K in Q1 2023. 16 funds tracked by Wall St. Rank hold CDIO as of Q1 2026.

  • PNC Financial Services Group reported no remaining Cardio Diagnostics position as of Q1 2026 after selling out during the quarter.
  • PNC Financial Services Group sold 1,350 Cardio Diagnostics shares in Q1 2026, an estimated $3.66K.
  • PNC Financial Services Group first reported a position in Cardio Diagnostics in Q1 2023 and held it in 12 quarters.
  • PNC Financial Services Group's Cardio Diagnostics position peaked at $158K in Q1 2023.
  • 16 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.